RadioPharm Theranostics
Carlton South
About RadioPharm Theranostics
RadioPharm Theranostics develops radiopharmaceutical products for diagnostic and therapeutic uses. They apply the potential of radiopharmaceuticals in treating oncological diseases. Their radiopharmaceuticals are safe radioactive drugs for use as diagnostic and therapeutic tools.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $11.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2025)
- Ticker: asx:RAD
- Website: radiopharmtheranostics.com
- Phone: +61 3 9824 5254
Industries & Categories
Biotechnology, Consulting, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/radiopharm-theranostics-119736 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.